Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

Simple item page
dc.contributor.authorBritton, Amadea
dc.contributor.authorEmbi, Peter J.
dc.contributor.authorLevy, Matthew E.
dc.contributor.authorGaglani, Manjusha
dc.contributor.authorDeSilva, Malini B.
dc.contributor.authorDixon, Brian E.
dc.contributor.authorDascomb, Kristin
dc.contributor.authorPatel, Palak
dc.contributor.authorSchrader, Kristin E.
dc.contributor.authorKlein, Nicola P.
dc.contributor.authorOng, Toan C.
dc.contributor.authorNatarajan, Karthik
dc.contributor.authorHartmann, Emily
dc.contributor.authorKharbanda, Anupam B.
dc.contributor.authorIrving, Stephanie A.
dc.contributor.authorDickerson, Monica
dc.contributor.authorDunne, Margaret M.
dc.contributor.authorRaiyani, Chandni
dc.contributor.authorGrannis, Shaun J.
dc.contributor.authorStenehjem, Edward
dc.contributor.authorZerbo, Ousseny
dc.contributor.authorRao, Suchitra
dc.contributor.authorHan, Jungmi
dc.contributor.authorSloan-Aagard, Chantel
dc.contributor.authorGriggs, Eric P.
dc.contributor.authorWeber, Zachary A.
dc.contributor.authorMurthy, Kempapura
dc.contributor.authorFadel, William F.
dc.contributor.authorGrisel, Nancy
dc.contributor.authorMcEvoy, Charlene
dc.contributor.authorLewis, Ned
dc.contributor.authorBarron, Michelle A.
dc.contributor.authorNanez, Juan
dc.contributor.authorReese, Sarah E.
dc.contributor.authorMamawala, Mufaddal
dc.contributor.authorValvi, Nimish R.
dc.contributor.authorArndorfer, Julie
dc.contributor.authorGoddard, Kristin
dc.contributor.authorYang, Duck-Hye
dc.contributor.authorFireman, Bruce
dc.contributor.authorBall, Sarah W.
dc.contributor.authorLink-Gelles, Ruth
dc.contributor.authorNaleway, Allison L.
dc.contributor.authorTenforde, Mark W.
dc.contributor.departmentBiomedical Engineering and Informatics, Luddy School of Informatics, Computing, and Engineering
dc.date.accessioned2024-06-05T17:19:24Z
dc.date.available2024-06-05T17:19:24Z
dc.date.issued2022-10-21
dc.eprint.versionFinal published version
dc.identifier.citationBritton, A., Embi, P. J., Levy, M. E., Gaglani, M., DeSilva, M. B., Dixon, B. E., Dascomb, K., Patel, P., Schrader, K. E., Klein, N. P., Ong, T. C., Natarajan, K., Hartmann, E., Kharbanda, A. B., Irving, S. A., Dickerson, M., Dunne, M. M., Raiyani, C., Grannis, S. J., … Tenforde, M. W. (2022). Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance—VISION Network, 10 States, December 2021—August 2022. Morbidity and Mortality Weekly Report, 71(42), 1335–1342. https://doi.org/10.15585/mmwr.mm7142a4
dc.identifier.urihttps://hdl.handle.net/1805/41237
dc.language.isoen_US
dc.publisherU.S. Department of Health & Human Services
dc.relation.isversionof10.15585/mmwr.mm7142a4
dc.relation.journalMorbidity and Mortality Weekly Report
dc.rightsCC0 1.0 Universalen
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/
dc.sourcePMC
dc.subjectCOVID-19
dc.subjectvaccine effectiveness
dc.subjectOmicron variant
dc.subjectimmunocompromised adults
dc.titleEffectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Britton2022Effectiveness-PubP.pdf
Size:
496.77 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Biomedical Engineering and Informatics Works